NeuroBo Pharmaceuticals CEO Richard Kang receives $427K in 2020
NeuroBo Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: June 15, 2021
NeuroBo Pharmaceuticals reported fiscal year 2020 executive compensation information on June 15, 2021.
In 2020, three executives at NeuroBo Pharmaceuticals received on average a compensation package of $373K, a 463% increase compared to previous year.
Average pay of disclosed executives at NeuroBo Pharmaceuticals
Richard Kang, Chief Executive Officer, received $427K in total. 71% of Kang's compensation, or $302K, was in salary. Kang also received $125K in bonus.
Mark Versavel, Chief Medical Officer, received a compensation package of $357K. 100% of the compensation package, or $357K, was in salary.
Nicola Shannon, Former Vice President, Clinical Operations, earned $334K in 2020, a 405% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on June 15, 2021.